Janux Therapeutics Inc (JANX)

EBITDA Growth

35.44%

Quarterly · Period ending:

JANX logo

JANX EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported35.44%
JANX Quarterly EBITDA YoY % (-73.14% → 35.44%)
High-resolution chart · PNG

JANX ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Janux Therapeutics Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
35.4414%
-3.928%
-59.7544%
13.5649%
-510.9848%
-61.5758%
-75.5055%
-148.9068%
67.9932%
16.3354%
28.3169%
32.7051%
-1.5316%
-27.5865%
-17.3008%
-53.1521%
-170.9511%
-485.8901%
-711.1786%
-755.6972%
-163.5319%
-73.1355%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.